Your search returned 6 results.

Results
	1.	Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. [electronic resource] by Lips, E H Mulder, L de Ronde, J J Mandjes, I A M Koolen, B B Wessels, L F A Rodenhuis, S Wesseling, J Producer: 20140210 In: Breast cancer research and treatment vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A simple system for grading the response of breast cancer to neoadjuvant chemotherapy. [electronic resource] by Rodenhuis, S Mandjes, I A M Wesseling, J van de Vijver, M J Peeters, M-J T D F Vrancken Sonke, G S Linn, S C Producer: 20100513 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics. [electronic resource] by Lips, E H Mulder, L de Ronde, J J Mandjes, I A M Vincent, A Vrancken Peeters, M T F D Nederlof, P M Wesseling, J Rodenhuis, S Producer: 20120515 In: Breast cancer research and treatment vol. 131 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure. [electronic resource] by Jebbink, M van Werkhoven, E Mandjes, I A M Wesseling, J Lips, E H Vrancken Peeters, M-J T D F Loo, C E Sonke, G S Linn, S C Falo Zamora, C Rodenhuis, S Producer: 20160505 In: Breast cancer research and treatment vol. 153 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer. [electronic resource] by Kroep, J R Linn, S C Boven, E Bloemendal, H J Baas, J Mandjes, I A M van den Bosch, J Smit, W M de Graaf, H Schröder, C P Vermeulen, G J Hop, W C J Nortier, J W R Producer: 20110308 In: The Netherlands journal of medicine vol. 68 Availability: No items available. Save to lists Add to cart (remove)
	6.	Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04). [electronic resource] by van Rossum, A G J Kok, M van Werkhoven, E Opdam, M Mandjes, I A M van Leeuwen-Stok, A E van Tinteren, H Imholz, A L T Portielje, J E A Bos, M M E M van Bochove, A Wesseling, J Rutgers, E J Linn, S C Oosterkamp, H M Producer: 20190422 In: European journal of cancer (Oxford, England : 1990) vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)